• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱泼斯坦-巴尔病毒(EBV)的潜伏膜蛋白2A(LMP2A)可诱导基因转录发生改变,这与霍奇金淋巴瘤里德-斯腾伯格细胞中观察到的情况相似。

Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.

作者信息

Portis Toni, Dyck Patricia, Longnecker Richard

机构信息

Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Ward 6-231, 303 East Chicago Ave, Chicago, IL 60611, USA.

出版信息

Blood. 2003 Dec 1;102(12):4166-78. doi: 10.1182/blood-2003-04-1018. Epub 2003 Aug 7.

DOI:10.1182/blood-2003-04-1018
PMID:12907455
Abstract

Epstein-Barr virus (EBV) is associated with the development of a variety of malignancies, including Hodgkin lymphoma. One of the few viral transcripts expressed in EBV-positive Hodgkin/Reed-Sternberg (HRS) cells of Hodgkin lymphoma is latent membrane protein 2A (LMP2A). This viral protein blocks B-cell receptor (BCR)-signaling in vitro. Furthermore, expression of LMP2A in developing B cells in vivo induces a global down-regulation of genes necessary for proper B-cell development. In this study we have analyzed gene transcription in primary B cells from LMP2A transgenic mice, LMP2A-expressing human B-cell lines, and LMP2A-positive and -negative EBV-infected lymphoblastoid cell lines (LCLs). We demonstrate that LMP2A increases the expression of genes associated with cell cycle induction and inhibition of apoptosis, alters the expression of genes involved in DNA and RNA metabolism, and decreases the expression of B-cell-specific factors and genes associated with immunity. Furthermore, many alterations in gene expression induced by LMP2A are similar to those recently described in HRS cells of Hodgkin lymphoma and activated, proliferating germinal center centroblasts/centrocytes. These correlations suggest that LMP2A expression in EBV-infected B cells may lead to the induction and maintenance of an activated, proliferative state that could ultimately result in the development of Hodgkin lymphoma.

摘要

爱泼斯坦-巴尔病毒(EBV)与多种恶性肿瘤的发生有关,包括霍奇金淋巴瘤。在霍奇金淋巴瘤的EBV阳性霍奇金/里德-斯腾伯格(HRS)细胞中表达的少数病毒转录本之一是潜伏膜蛋白2A(LMP2A)。这种病毒蛋白在体外可阻断B细胞受体(BCR)信号传导。此外,LMP2A在体内发育中的B细胞中的表达会导致正常B细胞发育所需基因的整体下调。在本研究中,我们分析了来自LMP2A转基因小鼠的原代B细胞、表达LMP2A的人B细胞系以及LMP2A阳性和阴性EBV感染的淋巴母细胞系(LCLs)中的基因转录。我们证明,LMP2A增加了与细胞周期诱导和凋亡抑制相关的基因的表达,改变了参与DNA和RNA代谢的基因的表达,并降低了B细胞特异性因子和与免疫相关的基因的表达。此外,LMP2A诱导的基因表达的许多变化与最近在霍奇金淋巴瘤的HRS细胞以及活化、增殖的生发中心中心母细胞/中心细胞中描述的变化相似。这些相关性表明,EBV感染的B细胞中LMP2A的表达可能导致激活、增殖状态的诱导和维持,最终可能导致霍奇金淋巴瘤的发生。

相似文献

1
Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.爱泼斯坦-巴尔病毒(EBV)的潜伏膜蛋白2A(LMP2A)可诱导基因转录发生改变,这与霍奇金淋巴瘤里德-斯腾伯格细胞中观察到的情况相似。
Blood. 2003 Dec 1;102(12):4166-78. doi: 10.1182/blood-2003-04-1018. Epub 2003 Aug 7.
2
Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.抑制 LMP2A 靶基因 EGR-1 可保护霍奇金淋巴瘤细胞免受 EBV 裂解周期的影响。
J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198.
3
Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.爱泼斯坦-巴尔病毒潜伏膜蛋白2A利用Notch1在体内改变B细胞特性。
Blood. 2009 Jan 1;113(1):108-16. doi: 10.1182/blood-2008-06-160937. Epub 2008 Sep 24.
4
Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.爱泼斯坦-巴尔病毒(EBV)的潜伏膜蛋白2A(LMP2A)在B细胞受体激活后会改变正常的转录调控。
Virology. 2004 Jan 20;318(2):524-33. doi: 10.1016/j.virol.2003.09.017.
5
Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.EB 病毒 LMP2A 通过调控 B 细胞转录因子 E47 和 PU.1 抑制 MHC Ⅱ类分子的表达。
Blood. 2015 Apr 2;125(14):2228-38. doi: 10.1182/blood-2014-08-594689. Epub 2015 Jan 28.
6
Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α production.EB 病毒 LMP2A 通过 Syk 和 PI3K 激活 B 细胞淋巴瘤中的 NF-κB,增加 MIP-1α 的产生。
J Med Virol. 2019 May;91(5):845-855. doi: 10.1002/jmv.25381. Epub 2019 Jan 4.
7
The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.爱泼斯坦-巴尔病毒癌蛋白潜伏膜蛋白-1可将生发中心B细胞重编程为霍奇金-里德-斯腾伯格样表型。
J Pathol. 2008 Sep;216(1):83-92. doi: 10.1002/path.2384.
8
Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.潜伏膜蛋白1(LMP1)和LMP2A协同作用促进爱泼斯坦-巴尔病毒诱导的脐带血人源化小鼠模型中的B细胞淋巴瘤,但这并非必需。
J Virol. 2017 Mar 13;91(7). doi: 10.1128/JVI.01928-16. Print 2017 Apr 1.
9
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.爱泼斯坦-巴尔病毒潜伏膜蛋白2A是一种B细胞受体模拟物,对B细胞存活至关重要。
Blood. 2007 Nov 15;110(10):3715-21. doi: 10.1182/blood-2007-05-090142. Epub 2007 Aug 6.
10
Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.爱泼斯坦-巴尔病毒LMP1和LMP2A驱动的生发中心B细胞淋巴增殖性疾病的小鼠模型
Proc Natl Acad Sci U S A. 2017 May 2;114(18):4751-4756. doi: 10.1073/pnas.1701836114. Epub 2017 Mar 28.

引用本文的文献

1
Awakening the sleeping giant: Epstein-Barr virus reactivation by biological agents.唤醒沉睡的巨人:生物制剂诱导 Epstein-Barr 病毒激活。
Pathog Dis. 2024 Feb 7;82. doi: 10.1093/femspd/ftae002.
2
A Mouse Model to Study the Pathogenesis of γ-herpesviral Infections in Germinal Center B Cells.用于研究生发中心 B 细胞中 γ 疱疹病毒感染发病机制的小鼠模型。
Cells. 2023 Dec 6;12(24):2780. doi: 10.3390/cells12242780.
3
CAR-T Cell Therapy for Classical Hodgkin Lymphoma.嵌合抗原受体T细胞疗法治疗经典型霍奇金淋巴瘤
Hemasphere. 2023 Nov 16;7(12):e971. doi: 10.1097/HS9.0000000000000971. eCollection 2023 Dec.
4
mRNA-based Vaccines Targeting the T-cell Epitope-rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti-Tumor Immunity in Mice.基于 mRNA 的疫苗针对 Epstein Barr 病毒潜伏蛋白的 T 细胞表位丰富域,在小鼠中引发了强大的抗肿瘤免疫。
Adv Sci (Weinh). 2023 Dec;10(35):e2302116. doi: 10.1002/advs.202302116. Epub 2023 Oct 27.
5
Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity.EBV、SARS-CoV-2 和 HLA Ⅰ类分子结合基序之间的共享致病性特征和序列,以及它们在自身免疫中可能发挥的作用。
Clin Rev Allergy Immunol. 2023 Aug;65(2):206-230. doi: 10.1007/s12016-023-08962-4. Epub 2023 Jul 28.
6
EBV and Lymphomagenesis.爱泼斯坦-巴尔病毒与淋巴瘤发生
Cancers (Basel). 2023 Apr 4;15(7):2133. doi: 10.3390/cancers15072133.
7
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.淋巴瘤中的代谢重编程及潜在治疗靶点
Int J Mol Sci. 2023 Mar 13;24(6):5493. doi: 10.3390/ijms24065493.
8
The impact of Epstein-Barr virus latent membrane protein 2A on the production of B cell activating factor of the tumor necrosis factor family (BAFF), APRIL and their receptors.EB 病毒潜伏膜蛋白 2A 对肿瘤坏死因子家族 B 细胞激活因子(BAFF)、APRIL 及其受体产生的影响。
Immun Inflamm Dis. 2022 Nov;10(11):e729. doi: 10.1002/iid3.729.
9
Liquid-liquid phase separation in tumor biology.液体-液体相分离在肿瘤生物学中的作用。
Signal Transduct Target Ther. 2022 Jul 8;7(1):221. doi: 10.1038/s41392-022-01076-x.
10
Clinical and Therapeutic Implications of Epstein-Barr Virus in HIV-Related Lymphomas.爱泼斯坦-巴尔病毒在HIV相关淋巴瘤中的临床及治疗意义
Cancers (Basel). 2021 Nov 4;13(21):5534. doi: 10.3390/cancers13215534.